Regular professional medical advice is vital in identifying potential side effects early and managing them effectively
Rights and permissions About this article Cite this article Calvo, SC., Egan, J
Tirzepatide achieves an average reduction of 22.5%, while retatrutide shows early indications of up to 24.2%
Confidential Phone Call: Your journey begins with a simple, no-obligation call to our compassionate admissions team
We assigned judgements at three levels (no concerns, some concerns and major concerns) to each domain and summarised judgements across domains to an overall assessment ranging across very low, low, moderate or high level of confidence [17, 25]
Both medications carry an FDA-boxed warning about a potential thyroid cancer risk based on animal studies